Kore Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$407K Sell
803
-157
-16% -$87.9K 0.07% 153
2022
Q2
$522K Buy
960
+170
+22% +$93.6K 0.08% 160
2022
Q1
$467K Buy
790
+60
+8% +$34.5K 0.06% 179
2021
Q4
$487K Sell
730
-950
-57% -$593K 0.06% 174
2021
Q3
$960K Buy
1,680
+157
+10% +$86.2K 0.1% 154
2021
Q2
$768K Buy
1,523
+17
+1% +$8.02K 0.09% 168
2021
Q1
$687K Buy
1,506
+100
+7% +$47.7K 0.09% 155
2020
Q4
$655K Buy
1,406
+227
+19% +$106K 0.1% 138
2020
Q3
$521K Buy
1,179
+59
+5% +$24.4K 0.1% 130
2020
Q2
$405K Sell
1,120
-152
-12% -$50.9K 0.08% 146
2020
Q1
$361K Buy
1,272
+734
+136% +$231K 0.09% 144
2019
Q4
$175K Buy
+538
New +$163K 0.03% 268
2019
Q3
Sell
-732
Closed -$215K 241
2019
Q2
$215K Buy
732
+34
+5% +$9.37K 0.05% 205
2019
Q1
$191K Buy
698
+681
+4,006% +$169K 0.04% 213
2018
Q4
$4K Buy
+17
New +$3.99K ﹤0.01% 739

Other funds holding TMO

Kore Private Wealth's TMO Position: Q3 2022 in Review

Kore Private Wealth reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q3 2022, selling an estimated $87.9K and leaving 803 shares worth $407K. The position accounts for 0.07% of the portfolio, ranked #153.

Kore Private Wealth first reported a position in TMO in Q4 2018 and has held it in 15 quarters since. The position peaked at $960K in Q3 2021. 2,267 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Kore Private Wealth held 803 shares of Thermo Fisher Scientific worth $407K as of Q3 2022.
  • Kore Private Wealth sold 157 Thermo Fisher Scientific shares in Q3 2022, an estimated $87.9K.
  • Thermo Fisher Scientific made up 0.07% of Kore Private Wealth's portfolio in Q3 2022, its #153 holding.
  • Kore Private Wealth first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 15 quarters since.
  • Kore Private Wealth's Thermo Fisher Scientific position peaked at $960K in Q3 2021.
  • 2,267 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.